Metraipolis › archive › dc_db33b4fc2834

Integration of genetic evidence to identify approved drug targets — Europe PMC PMID:42410617

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42410617
DOI
10.1186/s13073-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-18T11:10:16.171Z
SHA-256 of the archived text
446c1d626999d67f853555bf2e4ec512d81e901652da942aaee15fe692b7cc9d
Stable URL of this page
https://metraipolis.com/documento/dc_db33b4fc2834

How to cite

Integration of genetic evidence to identify approved drug targets — Europe PMC PMID:42410617 — Europe PMC (en), https://europepmc.org/article/MED/42410617 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db33b4fc2834 (Metraipolis archive dc_db33b4fc2834, sha256 446c1d626999d67f853555bf2e4ec512d81e901652da942aaee15fe692b7cc9d)
BibTeX
@misc{dcdb33b4fc2834,
  title = {Integration of genetic evidence to identify approved drug targets — Europe PMC PMID:42410617},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42410617},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db33b4fc2834; sha256 446c1d626999d67f853555bf2e4ec512d81e901652da942aaee15fe692b7cc9d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42410617. Agents can read the archived copy with the MCP tool read_document.